title: Guillain-Barré syndrome.
authors.forename: Jerrold B
authors.initials: JB
authors.lastname: Leikin
authors.forename: David P
authors.initials: DP
authors.lastname: Randall
authors.forename: Darshan N
authors.initials: DN
authors.lastname: Shah
authors.forename: Kami R
authors.initials: KR
authors.lastname: Mullings
authors.forename: Joseph T
authors.initials: JT
authors.lastname: Alleva
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Hudgins
mesh_terms: D003131:Combined Modality Therapy; D004185:Disability Evaluation; D004576:Electromyography / Q000379:methods; D005260:Female; D020275:Guillain-Barre Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D015994:Incidence; D008297:Male; D018908:Muscle Weakness / Q000503:physiopathology*; D010951:Plasma Exchange / Q000379:methods*; D011379:Prognosis; D012121:Respiration, Artificial; D012307:Risk Factors; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D007136:Immunoglobulins